Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ImmunoCellular Therapeutics
ImmunoCellular Therapeutics
ImmunoCellular Therapeutics: Clinical and Operational Goals On-Track
Fri, 01/14/11 - 08:23 pm
ImmunoCellular Therapeutics
goals
cancer stem cells
ImmunoCellular Therapeutics (IMUC): At the Forefront of Brain Tumor Treatment
Mon, 12/20/10 - 04:50 pm
ImmunoCellular Therapeutics
brain tumors
glioblastoma multiforme
Clovis Oncology
ImmunoCellular Therapeutics: At the forefront of targeting cancer stem cells
Tue, 11/9/10 - 09:13 am
ImmunoCellular Therapeutics
stem cells
oncology
cancer
cancer stem cells
ImmunoCellular Therapeutics CEO Explains Economic Significance of New Vaccine Manufacturing Method
Wed, 10/13/10 - 11:19 pm
vaccines
ImmunoCellular Therapeutics
Dendreon
glioblastoma multiforme
ImmunoCellular Therapeutics Selects Averion International Corp. to Conduct Phase II Glioblastoma Study
Thu, 09/16/10 - 10:43 am
ImmunoCellular Therapeutics
ImmunoCellular Therapeutics Announces Long-Term Disease-Free Survival Data from Phase I Study in Glioblastoma
Wed, 09/8/10 - 02:06 pm
ImmunoCellular Therapeutics
oncology
ImmunoCellular Therapeutics Issues Letter to Shareholders
Fri, 09/3/10 - 02:06 pm
ImmunoCellular Therapeutics
ImmunoCellular Therapeutics Announces Licensing Agreement with Targepeutics for Worldwide Intellectual Property Rights to Validated Immunotherapy Target
Tue, 06/22/10 - 12:57 pm
ImmunoCellular Therapeutics
Targepeutics
glioblastoma multiforme
brain cancer
IL13Ra2
Pages
« first
‹ previous
1
2
3
4